A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India

NCT02590250 · clinicaltrials.gov ↗

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence
Overactive Bladder

Interventions

BIOLOGICAL: botulinum toxin Type A

Sponsor

Allergan